These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 30631758)

  • 1. Entamoeba Histolytica: Updates in Clinical Manifestation, Pathogenesis, and Vaccine Development.
    Kantor M; Abrantes A; Estevez A; Schiller A; Torrent J; Gascon J; Hernandez R; Ochner C
    Can J Gastroenterol Hepatol; 2018; 2018():4601420. PubMed ID: 30631758
    [No Abstract]   [Full Text] [Related]  

  • 2. The future for vaccine development against Entamoeba histolytica.
    Quach J; St-Pierre J; Chadee K
    Hum Vaccin Immunother; 2014; 10(6):1514-21. PubMed ID: 24504133
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Entamoeba histolytica infection in men who have sex with men.
    Hung CC; Chang SY; Ji DD
    Lancet Infect Dis; 2012 Sep; 12(9):729-36. PubMed ID: 22917103
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intestinal amoebiasis: 160 years of its first detection and still remains as a health problem in developing countries.
    Carrero JC; Reyes-López M; Serrano-Luna J; Shibayama M; Unzueta J; León-Sicairos N; de la Garza M
    Int J Med Microbiol; 2020 Jan; 310(1):151358. PubMed ID: 31587966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune Response to the Enteric Parasite
    Uribe-Querol E; Rosales C
    Physiology (Bethesda); 2020 Jul; 35(4):244-260. PubMed ID: 32490746
    [No Abstract]   [Full Text] [Related]  

  • 6. Efficacy of a Gal-lectin subunit vaccine against experimental Entamoeba histolytica infection and colitis in baboons (Papio sp.).
    Abd Alla MD; Wolf R; White GL; Kosanke SD; Cary D; Verweij JJ; Zhang MJ; Ravdin JI
    Vaccine; 2012 Apr; 30(20):3068-75. PubMed ID: 22406457
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the C-Terminal Fragment of Entamoeba histolytica Gal/GalNAc Lectin Intermediate Subunit as a Vaccine Candidate against Amebic Liver Abscess.
    Min X; Feng M; Guan Y; Man S; Fu Y; Cheng X; Tachibana H
    PLoS Negl Trop Dis; 2016 Jan; 10(1):e0004419. PubMed ID: 26824828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential detection of Entamoeba histolytica, Entamoeba dispar and Entamoeba moshkovskii in fecal samples by nested PCR in the United Arab Emirates (UAE).
    ElBakri A; Samie A; Ezzedine S; Odeh RA
    Acta Parasitol; 2013 Jun; 58(2):185-90. PubMed ID: 23666654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Host-antibody inductivity of virulent Entamoeba histolytica and non-virulent Entamoeba moshkovskii in a mouse model.
    Khomkhum N; Leetachewa S; Pawestri AR; Moonsom S
    Parasit Vectors; 2019 Mar; 12(1):101. PubMed ID: 30867040
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Proteomic comparison of Entamoeba histolytica and Entamoeba dispar and the role of E. histolytica alcohol dehydrogenase 3 in virulence.
    Davis PH; Chen M; Zhang X; Clark CG; Townsend RR; Stanley SL
    PLoS Negl Trop Dis; 2009; 3(4):e415. PubMed ID: 19365541
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Opportunities and obstacles in developing a vaccine for Entamoeba histolytica.
    Miller-Sims VC; Petri WA
    Curr Opin Immunol; 2002 Oct; 14(5):549-52. PubMed ID: 12183151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Entamoeba histolytica: an update.
    Stauffer W; Ravdin JI
    Curr Opin Infect Dis; 2003 Oct; 16(5):479-85. PubMed ID: 14502002
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Host-pathogen interaction in amebiasis and progress in vaccine development.
    Huston CD; Petri WA
    Eur J Clin Microbiol Infect Dis; 1998 Sep; 17(9):601-14. PubMed ID: 9832261
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Poached egg appearance in intestinal amebiasis.
    Upadhyay R; Gupta N; Gogia P; Chandra S
    Gastrointest Endosc; 2012 Jul; 76(1):189-90. PubMed ID: 22726481
    [No Abstract]   [Full Text] [Related]  

  • 15. Antigenicity, immunogenicity and vaccine efficacy of the galactose-specific adherence protein of Entamoeba histolytica.
    Ravdin JI; Shain DC; Kelsall BL
    Vaccine; 1993; 11(2):241-6. PubMed ID: 8438621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vaccines for amoebiasis: barriers and opportunities.
    Stanley SL
    Parasitology; 2006; 133 Suppl():S81-6. PubMed ID: 17274850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pathophysiology of amoebiasis.
    Stanley SL
    Trends Parasitol; 2001 Jun; 17(6):280-5. PubMed ID: 11378035
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Public health and clinical importance of amoebiasis in Malaysia: a review.
    Tengku SA; Norhayati M
    Trop Biomed; 2011 Aug; 28(2):194-222. PubMed ID: 22041740
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Taxon-Specific Proteins of the Pathogenic
    König C; Honecker B; Wilson IW; Weedall GD; Hall N; Roeder T; Metwally NG; Bruchhaus I
    Front Cell Infect Microbiol; 2021; 11():641472. PubMed ID: 33816346
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Amebiasis].
    Andersen PL
    Ugeskr Laeger; 2000 Mar; 162(11):1537-41. PubMed ID: 10868107
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.